- Home
- TEVA vs NTNX Comparison
TEVA vs NTNX Comparison
Compare TEVA & NTNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- NTNX
- Stock Information
- Founded
- TEVA 1901
- NTNX 2009
- Country
- TEVA Israel
- NTNX United States
- Employees
- TEVA N/A
- NTNX N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- NTNX Computer Software: Prepackaged Software
- Sector
- TEVA Health Care
- NTNX Technology
- Exchange
- TEVA Nasdaq
- NTNX Nasdaq
- Market Cap
- TEVA 18.4B
- NTNX N/A
- IPO Year
- TEVA N/A
- NTNX 2016
- Fundamental
- Price
- TEVA $15.38
- NTNX $69.81
- Analyst Decision
- TEVA Strong Buy
- NTNX Buy
- Analyst Count
- TEVA 6
- NTNX 14
- Target Price
- TEVA $24.00
- NTNX $85.86
- AVG Volume (30 Days)
- TEVA 11.7M
- NTNX 2.7M
- Earning Date
- TEVA 05-07-2025
- NTNX 02-26-2025
- Dividend Yield
- TEVA N/A
- NTNX N/A
- EPS Growth
- TEVA N/A
- NTNX N/A
- EPS
- TEVA N/A
- NTNX N/A
- Revenue
- TEVA $16,544,000,000.00
- NTNX $2,318,206,000.00
- Revenue This Year
- TEVA $5.31
- NTNX $18.48
- Revenue Next Year
- TEVA $1.18
- NTNX $15.71
- P/E Ratio
- TEVA N/A
- NTNX N/A
- Revenue Growth
- TEVA 4.41
- NTNX 14.81
- 52 Week Low
- TEVA $12.51
- NTNX $43.35
- 52 Week High
- TEVA $22.80
- NTNX $79.99
- Technical
- Relative Strength Index (RSI)
- TEVA 38.74
- NTNX 46.13
- Support Level
- TEVA $15.28
- NTNX $70.33
- Resistance Level
- TEVA $15.80
- NTNX $76.25
- Average True Range (ATR)
- TEVA 0.52
- NTNX 2.29
- MACD
- TEVA -0.01
- NTNX -0.16
- Stochastic Oscillator
- TEVA 30.41
- NTNX 38.23
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.